UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021243
Receipt number R000024506
Scientific Title A study to identify factors that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire
Date of disclosure of the study information 2016/02/29
Last modified on 2021/09/02 09:23:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to identify factors that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire

Acronym

A study to identify factor that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire(SELECT BC-CONFIRM-FEEL 2)

Scientific Title

A study to identify factors that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire

Scientific Title:Acronym

A study to identify factor that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire(SELECT BC-CONFIRM-FEEL 2)

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify factors that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire at the time when we ask them to participate in the trial, SELECT BC-CONFIRM. Then we use the information to make the patients' entry more efficient in our future clinical trials.

Basic objectives2

Others

Basic objectives -Others

Obtain information that can contribute to informed consent in the planning and clinical practice of the future of the clinical trial

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

a comprehensive evaluation of factors that affect the "participation and refusal of the decision-making to the trial, SELECT BC-CONFIRM" with calculation of odds ratios, stratified analysis and multivariate analysis.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

This was carried out as accompanying study of SELECT BC-CONFIRM which was a randomized controlled study conducted in metastatic or recurrent breast cancer patients. Eligible patients were all of those who were asked to participate in SELECT BC-CONFIRM.

Key exclusion criteria

According to the SELECT BC-CONFIRM.

Target sample size

177


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shozo Ohsumi

Organization

NHO Shikoku Cancer Center

Division name

Department of Breast Oncology

Zip code


Address

160 Kou, Minamiumemoto-machi,Matsuyama City, Ehime Prefecture,Japan

TEL

+81-(0)89-999-1111

Email

sosumi@shikoku-cc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akira Yamao

Organization

Public Health Research Foundation

Division name

Comprehensive Support Project for Clinical Research

Zip code


Address

Nishiwaseda1-1-7, Shinjyuku-ku Tokyo, 169 -0051 Japan

TEL

03-5287-2636

Homepage URL

http://www.csp.or.jp/

Email

cspor-office@csp.or.jp


Sponsor or person

Institute

SELECT BC-CONFIRM executive committee

Institute

Department

Personal name



Funding Source

Organization

Public Health Research Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 03 Month 01 Day

Date of IRB

2011 Year 05 Month 18 Day

Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2014 Year 01 Month 09 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We handed a self-administered questionnaire to all study candidated.

SELECT BC-CONFIRM trial
UMIN ID :000005449


Management information

Registered date

2016 Year 02 Month 29 Day

Last modified on

2021 Year 09 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024506